These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37130476)
21. Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV). Franck S; Allwinn R; Rabenau HF; Doerr HW Zentralbl Bakteriol; 1999 Oct; 289(4):475-81. PubMed ID: 10603664 [TBL] [Abstract][Full Text] [Related]
22. Progress toward global eradication of poliomyelitis, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(12):253-6. PubMed ID: 11939704 [TBL] [Abstract][Full Text] [Related]
23. Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. Parker EP; Molodecky NA; Pons-Salort M; O'Reilly KM; Grassly NC Expert Rev Vaccines; 2015; 14(8):1113-23. PubMed ID: 26159938 [TBL] [Abstract][Full Text] [Related]
24. National serosurvey of poliovirus immunity in Australia, 1996-99. Gidding HF; Backhouse JL; Gilbert GL; Burgess MA Aust N Z J Public Health; 2005 Feb; 29(1):48-52. PubMed ID: 15782872 [TBL] [Abstract][Full Text] [Related]
25. Poliovirus Immunity among Children Aged 6-11 and 36-48 Months in 14 Polio High-Risk Provinces of Afghanistan: A Health-Facility-Based Study. Soofi SB; Martinez M; Farag NH; Hendley WS; Ehrhardt D; Ahmed I; Hussain I; Weldon W; Kassem AM Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298591 [TBL] [Abstract][Full Text] [Related]
26. Reaching the last one per cent: progress and challenges in global polio eradication. Kew O Curr Opin Virol; 2012 Apr; 2(2):188-98. PubMed ID: 22482715 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey. Xu J; Wang Q; Kuang S; Rong R; Zhang Y; Fu X; Tang W Hum Vaccin Immunother; 2021 Jul; 17(7):2125-2131. PubMed ID: 33759702 [TBL] [Abstract][Full Text] [Related]
28. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005 [TBL] [Abstract][Full Text] [Related]
29. Global progress toward certifying polio eradication and laboratory containment of wild polioviruses--August 2002-August 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Nov; 52(47):1158-60. PubMed ID: 14647019 [TBL] [Abstract][Full Text] [Related]
30. Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era. Bandyopadhyay AS; Singh H; Fournier-Caruana J; Modlin JF; Wenger J; Partridge J; Sutter RW; Zaffran MJ Emerg Infect Dis; 2019 Jul; 25(7):1363-1369. PubMed ID: 31082331 [TBL] [Abstract][Full Text] [Related]
31. Achieving high seroprevalence against polioviruses in Sri Lanka--results from a serological survey, 2014. Gamage D; Palihawadana P; Mach O; Weldon WC; Oberste SM; Sutter RW J Epidemiol Glob Health; 2015 Dec; 5(4 Suppl 1):S67-71. PubMed ID: 26166424 [TBL] [Abstract][Full Text] [Related]
32. Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands. Oostvogel PM; Rumke HC; Conyn-Van Spaendonck MA; van der Avoort HG; Leeuwenburg J; van Loon AM J Infect Dis; 2001 Dec; 184(11):1451-5. PubMed ID: 11709788 [TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002. Pires de Miranda M; Carmo Gomes M; Rebelo de Andrade H Euro Surveill; 2007 Jun; 12(6):E7-8. PubMed ID: 17991403 [TBL] [Abstract][Full Text] [Related]
34. Seroepidemiology of polioviruses among university students in northern Italy. Baldo V; Baldovin T; Cocchio S; Lazzari R; Saracino E; Bertoncello C; Buja A; Trevisan A Clin Vaccine Immunol; 2012 Aug; 19(8):1292-5. PubMed ID: 22739695 [TBL] [Abstract][Full Text] [Related]
35. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt. El-Sayed N; Al-Jorf S; Hennessey KA; Salama M; Watkins MA; Abdelwahab JA; Pallansch MA; Gary H; Wahdan MH; Sutter RW Vaccine; 2007 Jun; 25(27):5062-70. PubMed ID: 17543428 [TBL] [Abstract][Full Text] [Related]
36. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria. Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311 [TBL] [Abstract][Full Text] [Related]
37. Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico. Ferreyra-Reyes L; Cruz-Hervert LP; Troy SB; Huang C; Sarnquist C; Delgado-Sánchez G; Canizales-Quintero S; Holubar M; Ferreira-Guerrero E; Montero-Campos R; Rodríguez-Álvarez M; Mongua-Rodriguez N; Maldonado Y; García-García L PLoS One; 2017; 12(10):e0185594. PubMed ID: 29023555 [TBL] [Abstract][Full Text] [Related]
38. Immunity of the Croatian population to poliomyelitis--a serosurvey. Borcić B; Kruzić V; Kaić B; Ljubin-Sternak S; Ljubicić M; Dobrovsak-Sourek V Acta Med Croatica; 1998; 52(4-5):229-33. PubMed ID: 9988903 [TBL] [Abstract][Full Text] [Related]
40. Immunity status against poliomyelitis in childbearing women in a province of northern Italy. A cross-sectional analysis. Veronesi L; Affanni P; Verrotti di Pianella C; Colucci ME; Tanzi ML Ann Ig; 2013; 25(5):427-33. PubMed ID: 24048181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]